Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

s decreased 18% to $14.3 million in 2012 from $17.4 million in 2011.  In 2012 we experienced lower research and development costs than in the prior year due primarily to decreased manufacturing costs in the hearing and FMD programs, the closeout of the PACT trial, reduced personnel costs as a result of our reduction in force, reduced material costs for our funded programs, and reduced equipment purchases under our hearing and FMD programs.  These decreases were partially offset by increased outside costs for our other research programs as compared to 2011.

General and administrative expenses increased 17% to $9.1 million in 2012 from $7.8 million in 2011.  General and administrative expenses were higher in 2012 primarily due to personnel costs, which included approximately $1.3 million in non-recurring employment costs.

Fourth Quarter 2012 ResultsFor the fourth quarter ended December 31, 2012, GenVec reported a net loss of $3.2 million, or $0.24 per share, compared with a net loss of $2.5 million, or $0.19 per share, for the comparable prior year period.  The Company reported revenues of $1.5 million in the fourth quarter of 2012 compared to $3.4 million for the same period in 2011.  This decrease was primarily due to reduced revenue related to both our hearing loss and balance disorders program, $1.3 million, and FMD program, $0.2 million.  Reduced revenue in each case is due to a reduced work scope in the 2012 period as compared to the same period in 2011.  Research and development expenses decreased 21% in 2012 from $3.9 million in the fourth quarter of 2011 to $3.1 million in the fourth quarter of 2012 due mainly to reduced personnel and manufacturing costs.  General and administrative expenses in the fourth quarter of 2012 decreased 20% to $1.6 million from $2.0 million in the comparable period in 2011 primarily due to decreased personnel and recruiting costs, partially offset by higher professional costs.
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... FRANCISCO , July 1, 2015  goBalto, ... startup solutions, announced today unprecedented growth in serving ... is intense pressure to speed clinical trials and ... globalization, and paper-based methods have stalled these efforts," ... current status of clinical trials has encouraged Industry ...
(Date:7/1/2015)... Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company ... announced the election of Joseph J. Krivulka ... of Directors. Commenting on the election of ... Chairman and CEO of Prismic, stated, "We are delighted ... have accepted our invitation to join Prismic,s Board ...
(Date:7/1/2015)... DIEGO , July 1, 2015  Imprimis ... company focused on the development and commercialization of ... company will ring The Nasdaq stock market closing ... celebrating the growing success of its Go Dropless™ ... 3.6 million cataract procedures are performed annually in ...
Breaking Medicine Technology:goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... 14 Medizone International, Inc. (OTC Bulletin ... AsepticSure(TM) trials have begun at Innovation Park, Queen,s University. ... and second round of laboratory testing, this third round ... in order to obtain maximum bactericidal action in combination ...
... , TROY, Mich., Oct. 14 Somanetics Corporation (Nasdaq: ... an Exclusive Sublicense Agreement with Raba Equity Partners II, ... Somanetics has obtained exclusive rights, subject to specified rights ... Johns Hopkins University, to new cerebral autoregulation technology developed ...
Cached Medicine Technology:Medizone International Announces Third Round of AsepticSure 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
(Date:7/1/2015)... ... 01, 2015 , ... In the United States, summer has always been the ... Saudi Arabia and Dubai, the summer temperatures are so hot, that July vacationers often ... Sam Saleh of ORA Dentistry Spa notes that a trip to the United States, ...
(Date:7/1/2015)... NY (PRWEB) , ... July 01, 2015 , ... For ... DNA is wound, histones, remain constant in the brain, never changing after development in ... discovered that histones are steadily replaced in brain cells throughout life – a process ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... forms, such as organically raised chickens and eggs. Eating organic foods and products ... is cleaner and more environmentally friendly than production chicken farming. Choosing home raised ...
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® ... Corporation of America (HCA), as it further expands its Strategic Alliance Partnership Program ... With this new partnership, OncLive’s editorial and marketing teams will collaborate with Sarah ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow of U.S. ... 15-16th (MSG Keys’ birthday) in memory of her late husband and all of America’s ... of the Bronze Star Medal, died during a Special Forces training exercise in December ...
Breaking Medicine News(10 mins):Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3
... Patricia Hewitt, the health secretary said that computer based ... depression and anxiety//. This will be available to all ... programs- Fear fighter and Beating the blues have been ... However, health experts have warned that computer aided programs ...
... than making you look like one. It steers you towards a ... say researchers. , The report published in the journal ... Dr. David W. Dunstan and team from the International Diabetes Institute, ... who confessed to sedentary lives ruled by lots of TV and ...
... a genomic test may provide detailed information on how ... profiling (GEP) test, known as the Allomap test, is ... rejection instead of routine invasive heart muscle biopsies, but ... levels, the pressure in the heart before pumping, and ...
... that women with a recent diagnosis of cancer in one ... ,This study was conducted by the Chapel Hill ... international research team found that MRI, or magnetic resonance imaging, ... women (3.1 percent) who had recently been diagnosed with cancer ...
... and Company, a leading pharmaceutical manufacturer, has announced ... enzastaurin,// an anti-cancer drug the status of an ... the drug's manufacturer a seven-year right to exclusively ... drugs encourages their development by greatly increasing their ...
... abuse in the US is now being dubbed as a war on ... small part of the growing army of drug addicts, but they tend ... 2006 report by the American Civil Liberties Union, African Americans make up ... those arrested on drug charges. ,They also form 59 ...
Cached Medicine News:Health News:Computer Based Therapy For Depression 2Health News:Sedentary Lives Equal Shorter ‘sweeter’ Liv 2Health News:Gene Test Shown to Measure Heart Function After Transplant 2Health News:MRI Screening of Other Breast Crucial for Patients Diagnosed With Cancer in One Breast 2Health News:African Americans Tend to Suffer More from Drug Abuse 2
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
ApolipoproteinA-1 & B Calibrator...
CRP Calibrator...
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes...
Medicine Products: